• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.RNA聚合酶III转录的核酶在体内活性的调控因素。
J Virol. 1999 Mar;73(3):1868-77. doi: 10.1128/JVI.73.3.1868-1877.1999.
2
Construction of a ribozyme-expression system that effectively transports ribozymes to the cytoplasm.构建一种能有效将核酶转运至细胞质的核酶表达系统。
Nucleic Acids Symp Ser. 2000(44):203-4. doi: 10.1093/nass/44.1.203.
3
Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.胞质锤头状核酶的活性显著高于相应的核内对应物:具有延长3'末端的工程化tRNA能够在哺乳动物细胞中高效且特异地输出至胞质。
Nucleic Acids Res. 2001 Jul 1;29(13):2780-8. doi: 10.1093/nar/29.13.2780.
4
Ribozyme expression systems.核酶表达系统。
Methods Mol Biol. 2004;252:195-207. doi: 10.1385/1-59259-746-7:195.
5
Transport of intracellularly active ribozymes to the cytoplasm.细胞内活性核酶向细胞质的转运。
Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S96-101. doi: 10.1007/s002800100314.
6
Use of ribozymes in cellular aging research.核酶在细胞衰老研究中的应用。
Methods Mol Biol. 2007;371:209-26. doi: 10.1007/978-1-59745-361-5_16.
7
Formation of a catalytically active dimer by tRNA(Val)-driven short ribozymes.由tRNA(Val)驱动的短核酶形成催化活性二聚体。
Nat Biotechnol. 1998 Oct;16(10):961-5. doi: 10.1038/nbt1098-961.
8
tRNAVal-heterodimeric maxizymes with high potential as geneinactivating agents: simultaneous cleavage at two sites in HIV-1 Tat mRNA in cultured cells.具有作为基因失活剂高潜力的tRNAVal异二聚体大酶:在培养细胞中对HIV-1 Tat mRNA的两个位点同时进行切割。
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1886-91. doi: 10.1073/pnas.96.5.1886.
9
Design, characterization and testing of tRNA3Lys-based hammerhead ribozymes.基于tRNA3Lys的锤头状核酶的设计、表征及测试
Nucleic Acids Res. 1999 Apr 1;27(7):1698-708. doi: 10.1093/nar/27.7.1698.
10
Novel method for selection of tRNA-driven ribozymes with enhanced stability in mammalian cells.
Antisense Nucleic Acid Drug Dev. 2002 Oct;12(5):341-52. doi: 10.1089/108729002761381311.

引用本文的文献

1
Prevention of ribozyme catalysis through cDNA synthesis enables accurate RT-qPCR measurements of context-dependent ribozyme activity.通过cDNA合成防止核酶催化能够实现对上下文依赖性核酶活性的准确RT-qPCR测量。
RNA. 2025 Apr 16;31(5):633-645. doi: 10.1261/rna.080243.124.
2
Development and application of ribonucleic acid therapy strategies against COVID-19.针对 COVID-19 的核糖核酸治疗策略的开发和应用。
Int J Biol Sci. 2022 Aug 1;18(13):5070-5085. doi: 10.7150/ijbs.72706. eCollection 2022.
3
Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics.基因编辑和 RNAi 方法在 COVID-19 诊断和治疗中的应用。
Gene Ther. 2021 Jun;28(6):290-305. doi: 10.1038/s41434-020-00209-7. Epub 2020 Dec 14.
4
Antiviral Hammerhead Ribozymes Are Effective for Developing Transgenic Suppression of Chikungunya Virus in Aedes aegypti Mosquitoes.抗病毒锤头状核酶对在埃及伊蚊中开发转基因抑制基孔肯雅病毒有效。
Viruses. 2016 Jun 10;8(6):163. doi: 10.3390/v8060163.
5
Relieving bottlenecks in RNA drug discovery for retinal diseases.缓解视网膜疾病 RNA 药物研发中的瓶颈。
Adv Exp Med Biol. 2012;723:145-53. doi: 10.1007/978-1-4614-0631-0_20.
6
Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.治疗性转录后基因沉默剂开发中的变量与策略
J Ophthalmol. 2011;2011:531380. doi: 10.1155/2011/531380. Epub 2011 Jun 30.
7
Novel RNA-based strategies for therapeutic gene silencing.新型基于 RNA 的治疗性基因沉默策略。
Mol Ther. 2010 Mar;18(3):466-76. doi: 10.1038/mt.2009.306. Epub 2010 Jan 19.
8
Effective suppression of Dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome.使用针对病毒基因组的锤头状核酶进行逆转录病毒转导,在蚊细胞培养物中有效抑制登革热病毒。
Virol J. 2009 Jun 4;6:73. doi: 10.1186/1743-422X-6-73.
9
Development of lead hammerhead ribozyme candidates against human rod opsin mRNA for retinal degeneration therapy.开发针对人视杆细胞视蛋白mRNA的锤头状核酶候选物用于视网膜变性治疗。
Exp Eye Res. 2009 May;88(5):859-79. doi: 10.1016/j.exer.2008.11.018. Epub 2008 Dec 6.
10
A triplex ribozyme expression system based on a single hairpin ribozyme.一种基于单个发夹状核酶的三链核酶表达系统。
Oligonucleotides. 2008 Sep;18(3):213-24. doi: 10.1089/oli.2008.0130.

本文引用的文献

1
The Hydrolysis of RNA: From Theoretical Calculations to the Hammerhead Ribozyme-Mediated Cleavage of RNA.RNA的水解:从理论计算到锤头状核酶介导的RNA切割
Chem Rev. 1998 May 7;98(3):991-1026. doi: 10.1021/cr9604292.
2
A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo.
Mol Cell. 1998 Nov;2(5):617-27. doi: 10.1016/s1097-2765(00)80160-4.
3
Formation of a catalytically active dimer by tRNA(Val)-driven short ribozymes.由tRNA(Val)驱动的短核酶形成催化活性二聚体。
Nat Biotechnol. 1998 Oct;16(10):961-5. doi: 10.1038/nbt1098-961.
4
Explanation by a putative triester-like mechanism for the thio effects and Mn2+ rescues in reactions catalyzed by a hammerhead ribozyme.
FEBS Lett. 1998 Jul 17;431(2):154-60. doi: 10.1016/s0014-5793(98)00734-0.
5
Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation.共激活因子p300和CBP在视黄酸诱导的F9细胞分化中的不同作用。
Nature. 1998 May 21;393(6682):284-9. doi: 10.1038/30538.
6
Identification of a nuclear export receptor for tRNA.转运RNA核输出受体的鉴定
Curr Biol. 1998 Mar 12;8(6):305-14. doi: 10.1016/s0960-9822(98)70130-7.
7
A two-metal ion mechanism operates in the hammerhead ribozyme-mediated cleavage of an RNA substrate.双金属离子机制在锤头状核酶介导的RNA底物切割中起作用。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):542-7. doi: 10.1073/pnas.95.2.542.
8
Explanation by the double-metal-ion mechanism of catalysis for the differential metal ion effects on the cleavage rates of 5'-oxy and 5'-thio substrates by a hammerhead ribozyme.锤头状核酶通过双金属离子催化机制对5'-氧代和5'-硫代底物切割速率的不同金属离子效应的解释。
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14343-8. doi: 10.1073/pnas.94.26.14343.
9
Use of adenoviral VAI small RNA as a carrier for cytoplasmic delivery of ribozymes.使用腺病毒VAI小RNA作为核酶细胞质递送的载体。
RNA. 1997 Jun;3(6):677-87.
10
Observations on catalysis by hammerhead ribozymes are consistent with a two-divalent-metal-ion mechanism.对锤头状核酶催化作用的观察结果与双二价金属离子机制一致。
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2290-4. doi: 10.1073/pnas.94.6.2290.

RNA聚合酶III转录的核酶在体内活性的调控因素。

Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.

作者信息

Koseki S, Tanabe T, Tani K, Asano S, Shioda T, Nagai Y, Shimada T, Ohkawa J, Taira K

机构信息

National Institute for Advanced Interdisciplinary Research, AIST, MITI, Tsukuba Science City 305-8562, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8539, Japan.

出版信息

J Virol. 1999 Mar;73(3):1868-77. doi: 10.1128/JVI.73.3.1868-1877.1999.

DOI:10.1128/JVI.73.3.1868-1877.1999
PMID:9971765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC104427/
Abstract

In order to determine the parameters that govern the activity of a ribozyme in vivo, we made a systematic analysis of chimeric tRNAVal ribozymes by measuring their cleavage activities in vitro as well as the steady-state levels of transcripts, the half-lives of transcribed tRNAVal ribozymes, and their activities in both HeLa and H9 cells. These analyses were conducted by the use of transient expression systems in HeLa cells and stable transformants that express ribozymes. Localization of transcripts appeared to be determined by the higher-order structure of each transcribed tRNAVal ribozyme. Since colocalization of the ribozyme with its target RNA is important for strong activity of the ribozyme in vivo, the best system for tRNA-based expression seems to be one in which the structure of the transcript is different from that of the natural tRNA precursor so that processing of the tRNAVal ribozyme can be avoided. At the same time, the structure of the transcript must be similar enough to allow recognition, probably by an export receptor, so that the transcript can be exported to the cytoplasm to ensure colocalization with its target. In the case of several tRNAVal ribozymes that we constructed, inspection of computer-predicted secondary structures enabled us to control the export of transcripts. We found that only a ribozyme that was transcribed at a high level and that had a sufficiently long half-life, within cells, had significant activity when used to withstand a challenge by human immunodeficiency virus type 1.

摘要

为了确定在体内调控核酶活性的参数,我们通过测量嵌合tRNAVal核酶的体外切割活性、转录本的稳态水平、转录的tRNAVal核酶的半衰期及其在HeLa细胞和H9细胞中的活性,对其进行了系统分析。这些分析是通过在HeLa细胞中使用瞬时表达系统以及表达核酶的稳定转化体来进行的。转录本的定位似乎由每个转录的tRNAVal核酶的高级结构决定。由于核酶与其靶RNA的共定位对于核酶在体内的强大活性很重要,基于tRNA的表达的最佳系统似乎是转录本的结构不同于天然tRNA前体的结构的系统,这样可以避免tRNAVal核酶的加工。同时,转录本的结构必须足够相似以允许(可能通过输出受体)识别,以便转录本可以输出到细胞质中以确保与其靶标共定位。对于我们构建的几种tRNAVal核酶,检查计算机预测的二级结构使我们能够控制转录本的输出。我们发现,只有在细胞内高水平转录且半衰期足够长的核酶,在用于抵抗1型人类免疫缺陷病毒的攻击时才有显著活性。